[1]李文臣 孙奥 钟铁锴 王海峰.吉林省脑死亡判定自主呼吸激发试验的实施率和完成率分析[J].中国卫生质量管理,2022,29(03):022-25.[doi:10.13912/j.cnki.chqm.2022.29.3.07 ]
　LI Wenchen,SUN Ao,ZHONG Tiekai.Analysis of Implementation Rate and Completion Rate of Apnea Test in Brain Death Determination in Jilin Province[J].Chinese Health Quality Management,2022,29(03):022-25.[doi:10.13912/j.cnki.chqm.2022.29.3.07 ]
点击复制

吉林省脑死亡判定自主呼吸激发试验的实施率和完成率分析
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第29卷
期数:
2022年03期
页码:
022-25
栏目:
特别关注
出版日期:
2022-03-28

文章信息/Info

Title:
Analysis of Implementation Rate and Completion Rate of Apnea Test in Brain Death Determination in Jilin Province
作者:
李文臣 孙奥 钟铁锴 王海峰
吉林大学第一医院/吉林省脑损伤质控中心
Author(s):
LI Wenchen; SUN Ao; ZHONG Tiekai
The First Hospital of Jilin University/Brain Injury Quality Control Center of Jilin Province
关键词:
脑死亡判定;  自主呼吸激发试验;  实施率;  完成率
Keywords:
Brain Death Determination;  Apnea Test;  Implementation Rate;  Completion Rate
分类号:
R197.323；R741
DOI:
10.13912/j.cnki.chqm.2022.29.3.07
文献标志码:
A
摘要:
目的通过分析脑死亡判定自主呼吸激发试验（AT）的质控指标，探讨改进策略，提高AT的实施率和完成率。方法收集吉林省脑损伤质控中心2017年-2020年脑死亡判定病例相关资料，依据标准进行AT技术质控，分析AT实施率和完成率情况。结果AT实施率由2017年的4.3%提升至2020年的83.5%；完成率由2017年的66.7%提升至2020年的96.1%。实施AT后可出现严重酸中毒、低血压、低血氧、低血钾等风险，未实施AT和未完成AT的原因主要为血压、心率、血氧不稳定。结论通过医师间、医护间的技术合作，有利于提升实施AT的安全性。为进一步提升AT实施率和完成率，建议制定出现AT相关心跳骤停情况的不苛责机制，健全AT相关培训及考核制度。
Abstract:
ObjectiveTo improve the implementation rate and completion rate of Apnea Test (AT) by analyzing the quality control indicators of AT of brain death determination and discuss improvement strategy.MethodsThe relevant data of brain death determination cases from 2017 to 2020 in Brain Injury Quality Control Center of Jilin Province were collected, and AT technical quality control was conducted according to the standards, and the implementation rate and completion rate of AT were analyzed. ResultsThe implementation rate increased from 4.3% in 2017 to 83.5% in 2020, and the completion rate increased from 66.7% in 2017 to 96.1% in 2020. Severe acidosis, hypotension, hypoxemia,hypokalemia and other risks may occur after the implementation of AT. The main reasons for not implementing or completing AT were unstable blood pressure, heart rate and blood oxygen.Conclusion Technical cooperation between medical staff was beneficial to improve the safety of AT implementation. In order to further improve the implementation rate and completion rate of AT, it was suggested to establish a non-strict mechanism for the occurrence of AT-related cardiac arrest, and improve the training and assessment system of AT.

参考文献/References:

［1］国家卫生和计划生育委员会脑损伤质控评价中心.脑死亡判定标准与技术规范(成人质控版)［J］.中华神经科杂志,2013,46(9):637-640. ［2］国家卫生健康委员会脑损伤质控评价中心. 中国成人脑死亡判定标准与操作规范（第二版）［J］.中华医学杂志, 2019, 99(17):1288-1292. ［3］国家卫生健康委员会脑损伤质控评价中心, 中华医学会神经病学分会神经重症协作组, 中国医师协会神经内科医师分会神经重症专业委员会.脑死亡判定标准与操作规范：专家补充意见 （2021）［J］.中华医学杂志,2021, 101(23): 1758-1765. ［4］国家卫生健康委员会脑损伤质控评价中心, 中华医学会神经病学分会神经重症协作组, 中国医师协会神经内科医师分会神经重症专业委员会. 脑死亡判定实施与管理:专家指导意见(2021)［J］.中华医学杂志, 2021, 101(23): 1766-1771. ［5］宿英英.中国脑死亡判定现状与推进［J］.中华医学杂志, 2021, 101(23): 1721-1724. ［6］Daneshmand A, Rabinstein AA, Wijdicks EFM. The apnea test in brain death determination using oxygen diffusion method remains safe［J］.Neurology, 2019,92(8): 386-387. ［7］Su YY, Chen WB,Liu G, et al. An investigation and suggestions for the improvement of brain death determination in China［J］.Chin Med J(Engl),2018, 131(24):2910-2914. ［8］Datar S, Fugate J, Rabinstein A,et al. Completing the apnea test: decline in complications［J］.Neurocrit Care，2014,21(3):392-396. ［9］Wu XL, Fang Q, Li L, et al. Complications associated with the apnea test in the determination of the brain death［J］.Chin Med J(Engl), 2008, 121(13):1169-1172. ［10］Yee AH, Mandrekar J, Rabinstein AA, et al . Predictors of apnea test failure during brain death determination［J］.Neurocrit Care, 2010,12(3):352-355. ［11］Burns JD, Russell JA. Tension pneumothorax complicating apnea testing during brain death evaluation［J］.J Clin Neurosci, 2008,15(5): 580-582. ［12］Goudreau JL, Wijdicks EF, Emery SF. Complications during apnea testing in the determination of brain death: predi-sposing factors［J］.Neurology, 2000,55(7):1045-1048. ［13］王艳娟, 李瀚新,贾倩, 等. 器官捐献脑死亡判定中的护理配合［J］.现代临床护理, 2020,19(12):30-34. ［14］周明华，谭红，何思长, 等.公益性和积极性视角下我国公立医院绩效考核政策分析［J］.中国卫生质量管理，2020,27(6):107-110.

相似文献/References:

[1]宿英英.脑死亡判定质控工作思考与策略[J].中国卫生质量管理,2022,29(03):001.[doi:10.13912/j.cnki.chqm.2022.29.3.01 ]
　SU Yingying.Thinking and Strategy of Quality Control of Brain Death Determination[J].Chinese Health Quality Management,2022,29(03):001.[doi:10.13912/j.cnki.chqm.2022.29.3.01 ]
[2]宿英英刘刚张艳陈卫碧田飞范琳琳俞越黄丹赵国光.脑死亡判定质控指标的建立与应用[J].中国卫生质量管理,2022,29(03):004.[doi:10.13912/j.cnki.chqm.2022.29.3.02 ]
　SU Yingying.Establishment and Application of Quality Control Index for Brain Death Determination[J].Chinese Health Quality Management,2022,29(03):004.[doi:10.13912/j.cnki.chqm.2022.29.3.02 ]
[3]刘刚宿英英陈忠云黄荟瑾费晓璐魏岚梁志刚赵国光.脑死亡判定质量控制信息平台建设与应用[J].中国卫生质量管理,2022,29(03):007.[doi:10.13912/j.cnki.chqm.2022.29.3.03 ]
　LIU Gang,SU Yingying,CHEN Zhongyun.Construction and Application of Brain Death Determination Quality Control Information Platform[J].Chinese Health Quality Management,2022,29(03):007.[doi:10.13912/j.cnki.chqm.2022.29.3.03 ]
[4]张萍许峰连立飞梁奇明朱文浩朱遂强王芙蓉.以医院为基本单元的脑死亡判定质控团队建设[J].中国卫生质量管理,2022,29(03):011.[doi:10.13912/j.cnki.chqm.2022.29.3.04 ]
　ZHANG Ping,XU Feng,LIAN Lifei.Construction of the Quality Control Team for Brain Death Determination Based on Hospital[J].Chinese Health Quality Management,2022,29(03):011.[doi:10.13912/j.cnki.chqm.2022.29.3.04 ]
[5]张永芳吴永明王胜男王遥谭燕姜安琪刘国娥潘速跃.广东省脑死亡质控数据回顾分析及策略探讨[J].中国卫生质量管理,2022,29(03):015.[doi:10.13912/j.cnki.chqm.2022.29.3.05 ]
　ZHANG Yongfang,WU Yongming,WANG Shengnan.Retrospective Analysis and Strategy Discussion on Quality Control Data of Brain Death in Guangdong Province[J].Chinese Health Quality Management,2022,29(03):015.[doi:10.13912/j.cnki.chqm.2022.29.3.05 ]
[6]邓燕君邓卫康刘琦王俊代陆露徐平.贵州省脑死亡判定确认试验技术质控分析与改进[J].中国卫生质量管理,2022,29(03):018.[doi:10.13912/j.cnki.chqm.2022.29.3.06 ]
　DENG Yanjun,DENG Weikang,LIU Qi.Quality Control Analysis and Improvement of Brain Death Determination Confirmation Test Technology in Guizhou Province[J].Chinese Health Quality Management,2022,29(03):018.[doi:10.13912/j.cnki.chqm.2022.29.3.06 ]
[7]宿英英刘刚钱素云武洁张永芳邓燕君黄丹俞越荆婧刘海静党辉黄荟瑾赵国光.脑死亡判定精细化质控管理规范（2022版）[J].中国卫生质量管理,2022,29(12):023.[doi:10.13912/j.cnki.chqm.2022.29.12.06 ]
　SU Yingying,LIU Gang,QIAN Suyun.Refined Quality Control Management Specification for Brain Death Determination (2022)[J].Chinese Health Quality Management,2022,29(03):023.[doi:10.13912/j.cnki.chqm.2022.29.12.06 ]

更新日期/Last Update: 2022-03-28